X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12808) 12808
Book Review (2691) 2691
Publication (883) 883
Book Chapter (192) 192
Book / eBook (154) 154
Conference Proceeding (33) 33
Newsletter (24) 24
Dissertation (14) 14
Reference (5) 5
Web Resource (4) 4
Magazine Article (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (10333) 10333
humans (9670) 9670
male (5768) 5768
female (5598) 5598
middle aged (4737) 4737
aged (4234) 4234
gastroenterology & hepatology (3723) 3723
adult (3432) 3432
surgery (3211) 3211
oncology (2105) 2105
cancer (2083) 2083
liver (1888) 1888
aged, 80 and over (1719) 1719
retrospective studies (1659) 1659
treatment outcome (1598) 1598
carcinoma (1597) 1597
medicine & public health (1544) 1544
cholangiocarcinoma (1508) 1508
abridged index medicus (1469) 1469
animals (1246) 1246
prognosis (1188) 1188
primary biliary-cirrhosis (1139) 1139
risk factors (1116) 1116
diagnosis (1038) 1038
hepatocellular-carcinoma (1029) 1029
gastroenterology (1016) 1016
analysis (935) 935
management (933) 933
bile (903) 903
survival (876) 876
bile duct neoplasms - pathology (875) 875
chemotherapy (867) 867
pathology (865) 865
biliary tract (798) 798
tumors (794) 794
primary sclerosing cholangitis (791) 791
liver transplantation (781) 781
radiology, nuclear medicine & medical imaging (769) 769
bile duct neoplasms - surgery (720) 720
hepatology (708) 708
gallbladder (706) 706
health aspects (703) 703
liver diseases (698) 698
follow-up studies (686) 686
gastroenterology and hepatology (660) 660
survival rate (644) 644
adolescent (640) 640
care and treatment (633) 633
expression (632) 632
mortality (628) 628
research (627) 627
stents (624) 624
biliary tract neoplasms - pathology (623) 623
immunohistochemistry (608) 608
transplantation (608) 608
patients (589) 589
cholangiocarcinoma - pathology (578) 578
diagnosis, differential (574) 574
gemcitabine (564) 564
hilar cholangiocarcinoma (559) 559
time factors (558) 558
disease (555) 555
biliary (553) 553
cholangiopancreatography, endoscopic retrograde (553) 553
intrahepatic cholangiocarcinoma (553) 553
pancreas (551) 551
biliary-tract (545) 545
liver - pathology (545) 545
neoplasm staging (543) 543
gallbladder cancer (541) 541
hepatocellular carcinoma (540) 540
hepatectomy (537) 537
tomography, x-ray computed (535) 535
child (511) 511
biliary tract cancer (505) 505
risk-factors (498) 498
complications (496) 496
mice (495) 495
pancreatic cancer (490) 490
liver neoplasms - pathology (486) 486
survival analysis (485) 485
resection (482) 482
drainage (467) 467
prospective studies (465) 465
abdominal surgery (460) 460
cholangiography (458) 458
bile ducts, intrahepatic (456) 456
liver cirrhosis (450) 450
primary biliary cirrhosis (445) 445
biopsy (443) 443
adenocarcinoma (437) 437
cirrhosis (436) 436
liver neoplasms - surgery (435) 435
bile ducts, intrahepatic - pathology (433) 433
liver cancer (429) 429
cholangiocarcinoma - surgery (428) 428
biliary tract neoplasms - drug therapy (418) 418
young adult (412) 412
sensitivity and specificity (410) 410
medicine, general & internal (407) 407
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (106) 106
Online Resources - Online (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
Scarborough Hospital - General (2) 2
Credit Valley Hospital - Reference (1) 1
Gerstein Science - Reference (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Providence Healthcare - Reference (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UofT at Mississauga - Oversize (1) 1
UofT at Mississauga - Reference (1) 1
UofT at Mississauga - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12370) 12370
Japanese (224) 224
German (218) 218
French (156) 156
Spanish (79) 79
Korean (52) 52
Italian (24) 24
Chinese (18) 18
Russian (17) 17
Polish (9) 9
Bulgarian (5) 5
Hungarian (5) 5
Portuguese (5) 5
Czech (4) 4
Serbian (2) 2
Swedish (2) 2
Turkish (2) 2
Afar (1) 1
Croatian (1) 1
Danish (1) 1
Dutch (1) 1
Finnish (1) 1
Icelandic (1) 1
Norwegian (1) 1
Slovenian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Genetics, ISSN 1061-4036, 01/2013, Volume 45, Issue 1, pp. 72 - 75
Journal Article
Cancer, ISSN 0008-543X, 10/2002, Volume 95, Issue 8, pp. 1685 - 1695
BACKGROUND. To the authors' knowledge, the significance of postoperative adjuvant chemotherapy in pancreaticobiliary carcinoma has not yet been clarified. A... 
Adjuvant chemotherapy | Pancreatic carcinoma | Bile duct carcinoma | Disease-free survival | Carcinoma of the ampulla of Vater | Survival | Gallbladder carcinoma | BILIARY CARCINOMA | adjuvant chemotherapy | bile duct carcinoma | MITOMYCIN-C | ADENOCARCINOMA | survival | PANCREAS | P53 PROTEIN IMMUNOREACTIVITY | RADIATION-THERAPY | carcinoma of the ampulla of Vater | 5-FLUOROURACIL | EXTRAHEPATIC BILE-DUCT | CANCER-PATIENTS | pancreatic carcinoma | disease-free survival | ONCOLOGY | gallbladder carcinoma | EXPRESSION | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Male | Pancreatic Neoplasms - drug therapy | Fluorouracil - administration & dosage | Common Bile Duct Neoplasms - drug therapy | Adult | Female | Common Bile Duct Neoplasms - surgery | Chemotherapy, Adjuvant | Mitomycins - administration & dosage | Bile Duct Neoplasms - drug therapy | Bile Duct Neoplasms - surgery | Pancreatic Neoplasms - pathology | Pancreatic Neoplasms - surgery | Neoplasm Recurrence, Local | Disease-Free Survival | Gallbladder Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Gallbladder Neoplasms - pathology | Bile Duct Neoplasms - pathology | Infusions, Intravenous | Common Bile Duct Neoplasms - pathology | Gallbladder Neoplasms - surgery | Evaluation | Drug therapy | Postoperative care | Gallbladder cancer | Index Medicus | Abridged Index Medicus
Journal Article
世界肝病学杂志:英文版(电子版), ISSN 1948-5182, 2017, Volume 9, Issue 36, pp. 1378 - 1384
Primary biliary cholangitis(PBC) is a progressive cholestatic liver disease characterized by the presence of highly specific antimitochondrial antibodies,... 
Primary biliary cholangitis | Hepatocellular carcinoma | Combined hepatocellular carcinoma and cholangiocellular carcinoma | Case Report
Journal Article
BMC cancer, ISSN 1471-2407, 2015, Volume 15, Issue 1, pp. 564 - 564
Journal Article
Nature Genetics, ISSN 1061-4036, 2014, Volume 46, Issue 8, pp. 872 - 876
Journal Article
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 4/2017, Volume 52, Issue 4, pp. 512 - 519
Lenvatinib is an oral inhibitor of vascular endothelial growth factor receptor 1–3, fibroblast growth factor receptor 1–4, platelet-derived growth factor... 
E7080 | Medicine & Public Health | Tyrosine kinase inhibitor | Colorectal Surgery | Hepatology | Gastroenterology | Abdominal Surgery | Vascular endothelial growth factor inhibitor | Hepatocellular carcinoma | Lenvatinib | Surgical Oncology | MODIFIED RECIST | RESPONSE EVALUATION CRITERIA | SERUM | KINASE INHIBITOR | SORAFENIB | GASTROENTEROLOGY & HEPATOLOGY | ENDOTHELIAL GROWTH-FACTOR | Body Weight | Humans | Middle Aged | Male | Tomography, X-Ray Computed | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Quinolines - administration & dosage | Carcinoma, Hepatocellular - diagnostic imaging | Young Adult | Carcinoma, Hepatocellular - drug therapy | Antineoplastic Agents - adverse effects | Phenylurea Compounds - adverse effects | Aged, 80 and over | Adult | Female | Liver Neoplasms - pathology | Drug Administration Schedule | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Phenylurea Compounds - therapeutic use | Liver Neoplasms - diagnostic imaging | Disease Progression | Protein Kinase Inhibitors - administration & dosage | Phenylurea Compounds - administration & dosage | Protein Kinase Inhibitors - therapeutic use | Carcinoma, Hepatocellular - pathology | Aged | Quinolines - therapeutic use | Neoplasm Staging | Quinolines - adverse effects | Tyrosine | Complications and side effects | Medical research | Care and treatment | Medicine, Experimental | Hepatoma | Growth factors | Endothelium | Index Medicus | Original —Liver, Pancreas, and Biliary Tract
Journal Article